Diagnosis → Ophthalmology

Episcleritis

A self-limited inflammation of the episclera (the thin and superficial connective tissue between conjunctiva and sclera).

Also known as: Episcleral inflammation

Etiology

Cause [7vf][9fk]

Pathophysiology [9fk]

  1. An inflammatory response localized to the superficial episcleral vascular network

  2. Release inflammatory mediators --> vasodilation + increased vascular permeability

  3. Infiltration of lymphocytes, plasma cells, and macrophages along with edema

  4. Clinical presentation:

    • Eye redness

    • Mild ocular discomfort or pain

    • Discharge (rare)

    • Photophobia (rare)

    • No intraocular inflammation

  5. Diffuse episcleritis: 84% of cases

    • Intermittent bouts of inflammation

    • Last 7 to 10 days

    • Recur at 1-3-month intervals

  6. Nodular/focal episcleritis: 16% of cases

    • Prolonged attacks of inflammation

    • Typically more painful than diffuse episcleritis

    • Associated with systemic disease

Complications

Epidemiology

Incidence per 100.000 [c1a][vfy][t4o][ivb]

Default

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Blurred vision, Lacrimation, Photophobia, Red eye

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Pain
Radiates
Eyes
Onset
Subacute (hours)Gradual (days)
Pattern
IntermittentConstant
Provoked by
Sudden movement
Severity
Mild (1-3)Moderate (4-7)

Approach

Treatment

  1. Episcleritis is self-limited and will resolve without intervention within 2 to 21 days

  2. Treat the underlying condition

    • Infection --> appropriate antibiotic therapy

  3. Symptomatic treatment:

    • Artificial tears

    • Sunglasses

    • Mild topical corticosteroids if severe or prolonged symptoms

    • Systemic NSAIDs (Ibuprofen 200-600mg x 3/day)

    • Systemic corticosteroids

Differential diagnoses

Conjunctivitis, Foreign body, Glaucoma, Iridocyclitis, Keratitis, Keratoconjunctivitis sicca, Lymphoma, Scleritis, Subconjunctival hemorrhage


References

[1] https://www.ncbi.nlm.nih.gov/books/NBK534796/ (7th September 2026)

[2] https://emedicine.medscape.com/article/1228246 (7th September 2026)

[3] Xu TT, Reynolds MM, Hodge DO, Smith WM. Epidemiology and Clinical Characteristics of Episcleritis and Scleritis in Olmsted County, Minnesota. Am J Ophthalmol. 2020 Sep;217:317-324.

[4] Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, Parker JV, Vinoya AC, Uchida A, Acharya NR. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013 Oct;156(4):752-8.

[5] Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013 Dec;32(12):1562-6.

[6] Thong LP, Rogers SL, Hart CT, Hall AJ, Lim LL. Epidemiology of episcleritis and scleritis in urban Australia. Clin Exp Ophthalmol. 2020 Aug;48(6):757-766.

Scroll to top